tiprankstipranks
Oryzon Genomics (ES:ORY)
:ORY
Spanish Market

Oryzon Genomics SA (ORY) Financial Statements

Compare
12 Followers

Oryzon Genomics SA Financial Overview

Oryzon Genomics SA's market cap is currently €174.51M. The company's EPS TTM is €-0.064; its P/E ratio is ―; Oryzon Genomics SA is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is €-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 14.19M€ 0.00€ 0.00€ 0.00€ 0.00
Gross Profit€ 13.95M€ 15.23M€ 9.87M€ 8.99M€ 0.00
Operating Income€ -4.55M€ -5.49M€ -7.01M€ -4.29M€ -10.55M
EBITDA€ -4.43M€ -5.35M€ -6.88M€ -4.16M€ -3.70M
Net Income€ -3.35M€ -4.23M€ -4.69M€ -3.40M€ 0.00
Balance Sheet
Cash & Short-Term Investments€ 12.26M€ 21.32M€ 28.72M€ 39.60M€ 141.56K
Total Assets€ 106.90M€ 103.70M€ 95.38M€ 94.11M€ 0.00
Total Debt€ 13.69M€ 17.44M€ 13.77M€ 9.09M€ 0.00
Net Debt€ 1.43M€ -3.88M€ -14.95M€ -30.51M€ 0.00
Total Liabilities€ 25.13M€ 31.13M€ 24.12M€ 18.18M€ 79.38K
Stockholders' Equity€ 81.77M€ 72.57M€ 71.26M€ 75.93M€ 0.00
Cash Flow
Free Cash Flow€ -15.08M€ -16.12M€ -15.39M€ -14.04M€ 0.00
Operating Cash Flow€ -574.96K€ -1.85M€ -3.63M€ -4.82M€ 0.00
Investing Cash Flow€ -14.50M€ -14.27M€ -11.72M€ -9.08M€ 0.00
Financing Cash Flow€ 6.02M€ 8.71M€ 4.12M€ 18.38M€ 0.00
Currency in EUR

Oryzon Genomics SA Earnings and Revenue History

Oryzon Genomics SA Debt to Assets

Oryzon Genomics SA Cash Flow

Oryzon Genomics SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis